 |
Testosterone |
|---|---|
| Trade Name | Theraderm Testosterone Transdermal System |
| Orphan Indication | For use as physiologic testosterone replacement in androgen deficient HIV+ patients with an associated weight loss |
| USA Market Approval | USA |
| USA Designation Date | 1997-09-22 00:00:00 |
| Sponsor | Watson Laboratories;Research Park, 417 Wakara Way;Salt Lake City, Utah, 84108 |
